Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer

References

• Lewis R. Prostate Cancer Screening. Physician Assistant Clinics. 2018;3:1–9.
   Web of Science ®Google Scholar
• Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5:378–387.
   PubMed Web of Science ®Google Scholar
• Park YH, Seo SY, Lee E, et al. Simvastatin induces apoptosis in castrate resistant prostate cancer cells by deregulating nuclear factor-κB pathway. J Urol. 2013;189:1547–1552.
   PubMed Web of Science ®Google Scholar
• Ahmadi Y, Ghorbanihaghjo A, Argani H. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms. Chemico-Biological Interactions. 2017;273:273–285.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Loria P. Potential for statins in the chemoprevention and management of hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;27:1654–1664.
   PubMed Web of Science ®Google Scholar
• Tsan Y-T, Lee C-H, Ho W-C, et al. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. JCO. 2013;31:1514–1521.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee SH, Hur KY, et al. Statins and the risk of gastric cancer in diabetes patients. BMC Cancer. 2012;12:596.
   PubMed Web of Science ®Google Scholar
• Khurana V, Bejjanki HR, Caldito G, et al. Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. CHEST. 2007;131:1282–1288.
   PubMed Web of Science ®Google Scholar
• Ahmaditabar P, Momtazi‐Borojeni AA, Rezayan AH, et al. Enhanced entrapment and improved in vitro controlled release of n‐acetyl cysteine in hybrid PLGA/lecithin nanoparticles prepared using a nanoprecipitation/self‐assembly method. J Cell Biochem 2017;118(12):4203–4209
   Web of Science ®Google Scholar
• Platz EA, Leitzmann MF, Visvanathan K, et al. Statin drugs and risk of advanced prostate cancer. JNCI. 2006;98:1819–1825.
   PubMed Web of Science ®Google Scholar
• Jun SW, Kim M-S, Kim J-S, et al. Preparation and characterization of simvastatin/hydroxypropyl-β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharma Biopharma. 2007;66:413–421.
   PubMed Web of Science ®Google Scholar
• Greenwood J, Steinman L, Zamvil SS. Statin therapy in autoimmunity: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006;6:358.
   PubMed Web of Science ®Google Scholar
• Chang CC, Ho SC, Chiu HF, et al. Statins increase the risk of prostate cancer: a population-based case-control study. Prostate. 2011;71:1818–1824.
   PubMed Web of Science ®Google Scholar
• Rosenson RS. Current overview of statin-induced myopathy. Am J Med. 2004;116:408–416.
   PubMed Web of Science ®Google Scholar
• Taylor ML, Wells BJ, Smolak MJ. Statins and cancer: a meta-analysis of case-control studies. Eur J Cancer Prev. 2008;17:259–268.
   PubMed Web of Science ®Google Scholar
• Pocobelli G, Newcomb PA, Trentham A., et al. Statin use and risk of breast cancer. Cancer. 2008;112:27–33.
   PubMed Web of Science ®Google Scholar
• Baron JA. Statins and the colorectum: hope for chemoprevention? Cancer Prev Res. 2010;3:573–575.
   PubMed Web of Science ®Google Scholar
• Alam M, Ahmed S, N, et al. Chemical engineering of a lipid nano-scaffold for the solubility enhancement of an antihyperlipidaemic drug, simvastatin; preparation, optimization, physicochemical characterization and pharmacodynamic study. Artif Cell Nanomed Biotechnol. 2017;1–12.
   Web of Science ®Google Scholar
• Muzykantov VR. Targeted drug delivery to endothelial adhesion molecules. ISRN Vascul Med. 2013;2013:1.
   Google Scholar
• Kawashima Y. Nanoparticulate systems for improved drug delivery. Adv Drug Deliv Rev. 2001;47:1–2.
   PubMed Web of Science ®Google Scholar
• Rajalakshmi S, Vyawahare N, Pawar A, et al. Current development in novel drug delivery systems of bioactive molecule plumbagin. Artif Cell Nanomed Biotechnol. 2018;1–10. doi:10.1080/21691401.2017.1417865
   PubMed Web of Science ®Google Scholar
• Sivasami P, Hemalatha T. Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives. Artif Cell Nanomed Biotechnol. 2018;1–12. doi:10.1080/21691401.2018.1442345
   PubMed Web of Science ®Google Scholar
• Naves L, Dhand C, Almeida L, et al. Poly (lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview. Prog Biomater. 2017;6:1–11.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Alam MA, Ahmad R, et al. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Artif Cell Nanomed Biotechnol. 2018;46:432–446.
   PubMed Web of Science ®Google Scholar
• Gentile P, Chiono V, Carmagnola I, et al. An overview of poly (lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Ijms. 2014;15:3640–3659.
   Web of Science ®Google Scholar
• Ahmadkhani L, Akbarzadeh A, Abbasian M. Development and characterization dual responsive magnetic nanocomposites for targeted drug delivery systems. Artif Nanomed Biotechnol 2018;46(5):1052–1063.
   PubMed Web of Science ®Google Scholar
• El-Sherbiny IM, Smyth HDC. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharma. 2012;9:269–280.
   PubMed Web of Science ®Google Scholar
• Ali IH, Khalil IA, El-Sherbiny IM. Single-dose electrospun nanoparticles-in-nanofibers wound dressings with enhanced epithelialization, collagen deposition, and granulation properties. ACS Appl Mater Interfaces. 2016;8:14453–14469.
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Jawalkar SS, Aminabhavi TM. Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size, and drug release. Eur J Pharm Biopharm. 2006;63:249–261.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. Aaps J. 2010;12:263–271.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharma Sci. 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Senthilraja P, Kathiresan K. In vitro cytotoxicity MTT assay in Vero. HepG2 and MCF-7 Cell Lines Study of Marine Yeast. J Appl Pharm Sci. 2015;5(3):080–084.
   Google Scholar
• Liu T-Y, Tan Z-J, Jiang L, et al. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int. 2013;13:64.
   PubMed Web of Science ®Google Scholar
• Sedeky AS, Khalil IA, Hefnawy A, et al. Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line. Eur J Pharm Sci. 2018;118:103–112.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Ibrahim HS, Abdel-Aziz HA, et al. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eur J Med Chem. 2015;89:549–560.
   PubMed Web of Science ®Google Scholar
• Morrison RTB, Robert Neilson, editor. Organic Chemistry/Edition 6. 6 ed: J. Chem. Educ. 1992;69 (11):A305. doi:10.1021/ed069pA305.2
   Google Scholar
• Xiao H, Wang L. Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery. Int J Nanomed. 2015;10:5309.
   PubMed Web of Science ®Google Scholar
• Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomed. 2007;2:219–232.
   PubMed Web of Science ®Google Scholar
• Arruebo M, Fernández-Pacheco R, Ibarra MR, et al. Magnetic nanoparticles for drug delivery. Nano Today. 2007;2:22–32.
   Web of Science ®Google Scholar
• Thapa D, Palkar V, Kurup M, et al. Properties of magnetite nanoparticles synthesized through a novel chemical route. Mater Lett. 2004;58:2692–2694.
   Web of Science ®Google Scholar
• Cui Y, Zhang M, Zeng F, et al. Dual-targeting magnetic PLGA nanoparticles for co-delivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces. 2016;8:32159–32169.
   PubMed Web of Science ®Google Scholar
• Ebrahimi E, Khandaghi AA, Valipour F, et al. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers. Artif Cell Nanomed Biotechnol. 2016;44:550–558.
   PubMed Web of Science ®Google Scholar
• Mosafer J, Teymouri M. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods. Artif Cell Nanomed Biotechnol. 2018;46:1146–1155.
   PubMed Web of Science ®Google Scholar
• Shabestari Khiabani S, Farshbaf M, Akbarzadeh A, et al. Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cell Nanomed Biotechnol. 2017;45:6–17.
   PubMed Web of Science ®Google Scholar
• Whittinghill J, Norton J, Proctor A. A Fourier transform infrared spectroscopy study of the effect of temperature on soy lecithin-stabilized emulsions. Vol. 76. 1999.
   Google Scholar
• Nzai J, Proctor A. Soy lecithin phospholipid determination by fourier transform infrared spectroscopy and the acid digest/arseno-molybdate method: a comparative study. J Am Oil Chem Soc. 1999;76:61–66.
   Web of Science ®Google Scholar
• Dillen K, Vandervoort J, Van den Mooter G, et al. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharma. 2006;314:72–82.
   PubMed Web of Science ®Google Scholar
• Swain RP, Pendela S, Panda S. Formulation and evaluation of gastro-bilayer floating tablets of simvastatin as immediate release layer and atenolol as sustained release layer. Ijps. 2016;78:458–468.
   Google Scholar
• Aguilar ZP. Chapter 5 - Targeted Drug Delivery. Nanomaterials for Medical Applications. USA: Elsevier; 2013. p. 181–234.
   Google Scholar
• Lu X-Y, Wu D-C, Li Z-J, et al. Chpater 7 - Polymer Nanoparticles. In: Villaverde A, editor. Progress in Molecular Biology and Translational Science. Vol. 104. USA: Academic Press; 2011. p. 299–323.
   Google Scholar
• Kochuparambil ST, Al-Husein B, Goc A, et al. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression. J Pharmacol Exp Ther. 2011;336:496–505.
   PubMed Web of Science ®Google Scholar
• Elbaz NM, Khalil IA, Abd-Rabou AA, et al. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. Int J Biol Macromol. 2016;92:254–269.
   PubMed Web of Science ®Google Scholar
• Altwairgi AK. Statins are potential anticancerous agents (review). Oncol Rep. 2015;33:1019–1039.
   PubMed Web of Science ®Google Scholar